Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune ResponseCarolyn Shembrey, Frédéric Hollande|Cancers|2019Cited by 48
Targeting of TP53-independent cell cycle checkpoints overcomes FOLFOX resistance in Metastatic Colorectal CancerCorina Behrenbruch, Frédéric Hollande|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 6